BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37189181)

  • 1. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
    de Jong MK; Rappoldt A; Broere F; Piek CJ
    Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
    Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
    Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic diarrhea secondary to canine leishmaniosis: Case series.
    López MC; Bertolani C; Sainz A; Tabar MD; Roura X
    Comp Immunol Microbiol Infect Dis; 2022; 90-91():101897. PubMed ID: 36274335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
    Daza González MA; Miró G; Fermín Rodríguez M; Rupérez Noguer C; Fragío Arnold C
    Res Vet Sci; 2019 Oct; 126():131-138. PubMed ID: 31491669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
    Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
    Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
    Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.
    Daza González MA; Fragío Arnold C; Fermín Rodríguez M; Checa R; Montoya A; Portero Fuentes M; Rupérez Noguer C; Martínez Subiela S; Cerón JJ; Miró G
    Vet J; 2019 Mar; 245():22-28. PubMed ID: 30819422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis.
    Gizzarelli M; Foglia Manzillo V; Inglese A; Montagnaro S; Oliva G
    Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi).
    Noli C; Saridomichelakis MN
    Vet J; 2014 Dec; 202(3):425-35. PubMed ID: 25266647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
    Segarra S; Miró G; Montoya A; Pardo-Marín L; Boqué N; Ferrer L; Cerón J
    Vet Parasitol; 2017 May; 239():50-56. PubMed ID: 28495197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
    Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R
    Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
    Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
    Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
    Martínez-Subiela S; Bernal LJ; Cerón JJ
    Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
    Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
    Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.